SHIRE ADDERALL XR PARAGRAPH IV NOTICE RECEIVED FROM ANDRX

Shire announces Tuesday that it has received a Paragraph IV notice letter from Andrx Pharmaceuticals, L.L.C. (Andrx) advising of the filing of an Abbreviated New Drug Application (ANDA) for its amphetamine combination product, a generic version of Shire's mixed amphetamine salt product, ADDERALL XR.

Easy Bourse (http://www.easybourse.com/Website/dynamic/News.php?NewsID=66065&lang=fra&NewsRubrique=2)